Transcriptomics

Dataset Information

0

Transcriptome analysis profile to understand mechanisms activated by FDA molecules that overcome the ATP7B mediated resistance to cisplatin in ovarian cancer IGROV-CP20 cells.


ABSTRACT: To understand whether treatments with FDA drugs Trelmisartan, Tranilast or Amphotericin B were able to downregulate pathways important to overcome resistance to cisplatin in ovarian cancer cells IGROV-0CP20 we cemployed Quant-seq Analysis.Transcriptome of the of IGROV-CP20 cells treated with cisplatin and each of the three FDA molecules were compared with untreated cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE134029 | GEO | 2020/04/13

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA553517 | ENA
| PRJNA311513 | ENA
2008-11-29 | GSE13763 | GEO
2023-09-19 | GSE237122 | GEO
2023-09-18 | GSE237121 | GEO
2009-01-13 | E-GEOD-13763 | biostudies-arrayexpress
2019-12-16 | E-MTAB-7683 | biostudies-arrayexpress
| PRJNA294416 | ENA
2014-03-19 | MSV000078567 | GNPS
| PRJNA316321 | ENA